SENTIO MMG Gen 2
K-Number: K173526 · 2018-04-05
ApplicantMedos International SARL
Decision Date2018-04-05
Product CodePDQ
Advisory CommitteeEN
DecisionSubstantially Equivalent
Device Summary
SENTIO MMG Gen 2 is a medical device manufactured by Medos International SARL. It received FDA 510(k) clearance on 2018-04-05 under approval number K173526. The device is classified under product code PDQ. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the SENTIO MMG Gen 2?
SENTIO MMG Gen 2 is a medical device that received FDA 510(k) clearance on 2018-04-05. It is manufactured by Medos International SARL. The 510(k) number is K173526.
When was SENTIO MMG Gen 2 approved by the FDA?
SENTIO MMG Gen 2 received FDA 510(k) clearance on 2018-04-05, under approval number K173526.
What company makes SENTIO MMG Gen 2?
SENTIO MMG Gen 2 is manufactured by Medos International SARL.
What is the FDA product code for SENTIO MMG Gen 2?
The FDA product code for SENTIO MMG Gen 2 is PDQ.
Other Devices by Medos International SARL
K162247PERMATAPE
K162327COUGAR® LS Lateral Cage System and COUGAR® System
K162912VIPER PRIME additions to the VIPER® System
K163106CODMAN Integrated Bipolar Cord and Tubing Set
K161638SPEEDTRAP Graft Preparation System
K162469CODMAN VersaTru Standard Disposable Non-Stick Bipolar Forceps, CODMAN VersaTru Slim Disposable Non-Stick Bipolar Forceps
Related Devices (Code: PDQ)
K161893Neuromonitoring KitSI-BONE, Inc.
K152747DSG Threaded Drill SystemSpineguard S.A.
K152942NuVasiveNVM5 SystemNu Vasive, Incorporated
K171807ES2 Neuromonitoring Accessory InstrumentsStryker Corporation
K162313NuVasive Next Generation NVM5 SystemNu Vasive, Incorporated
K181559Neurosign V4 Intraoperative Nerve MonitorMagstim Company, Ltd.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.